4basebio Stock

Detail Data
Volume (24h): 3 shares
P/E Ratio: /
Forward P/E: -0.20
EPS: -0.78 GBp
Forward EPS: -60 GBp
Number of Shares: 15,471,900 shares
Market Capitalization: 184,522,160.00 GBp

Dividend

Dividend Value
Dividend Amount According to our data, the company 4basebio does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a buy recommendation for 4basebio stock. The current number of analysts covering this company is 2. The highest target price is 1800 GBp, while the lowest target price is 1600 GBp. The median target valuation set by analysts is 1700 GBp. These forecasts and recommendations provide insight into how analysts view the future stock performance of 4basebio.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for 4basebio stock is: buy
Number of Analysts: 2
Highest Target Price: 1800 GBp
Lowest Target Price: 1600 GBp
Median Target Price: 1700 GBp

Fundamental Indicators

Indicator Data
Total Revenue: 596,000.00 GBp
Net Income: -9,838,000.00 GBp
Price-to-Book (P/B): /
PEG Ratio: /
Exchange: LSE
Industry: Biotechnology
Sector: Healthcare
Number of Employees: 101
Country: United Kingdom

Where to Buy 4basebio Stock?

You can purchase 4basebio stock on the LSE under the ticker symbol: 4BB.L. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on 4basebio Stock

Indicator Value
Company Revenue: 596,000.00 GBp
EBITDA: -9,633,000.00 GBp - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -0.78 GBp
Book Value Per Share: -0.41 GBp
Total Cash: 2,718,000.00 GBp
Total Cash per Share: 0.21 GBp
Total Debt: 15,494,000.00 GBp
Debt to Equity Ratio: -
Quick Ratio 1.54
Current Ratio 2.73
Free Cash Flow -7,063,500.00 GBp
Operating Cash Flow -8,332,000.00 GBp
Gross Margins 69.63 %
EBITDA Margins -
Operating Margins -1,767.99 %
Profit Margins -
Return on Assets -54.3 %
Return on Equity -
Earnings Growth (1 year) -
Revenue Growth (1 year) 37.8 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 184,522,160.00 GBp
Enterprise Value 163,877,456.00 GBp
EV/Revenue 274.962
EV/EBITDA -17.012
Float Shares 5,375,370 shares
Shares Outstanding 15,471,900 shares
Held Percent Insiders 0.61 %
Held Percent Institutions 14.19 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 1.09
Short Percentage of Float -
Implied Shares Outstanding 15,537,400

Frequently Asked Questions (FAQ)

According to our data, the company 4basebio does not pay dividends yet, even in 2025.

4basebio shares are traded on the LSE stock exchange under the ticker: 4BB.L. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for 4basebio shares is from a total of 2 analysts. The average target price prediction is 1700 GBp per share.

The total number of 4basebio shares on the exchange is 15,471,900.00 shares, which at the current market capitalization gives the company a total valuation of 184,522,160.00 GBp.